CD8A and neoplasm: In this study, we have demonstrated that despite great efforts, there is room for improvement to achieve accurate and reliable predictions of CD8+ T cell targets for an emerging virus such as SARS-CoV-2, or for a tumor of interest for the purpose of developing personalized (or stratified) treatments.